Georgia Governor Brian Kemp has signed Senate Bill 220 (SB 220) into law, expanding according to an Atlanta News First report. This legislation broadens patient eligibility for the state’s low-THC oil program and introduces new methods of administration, impacting Georgia medical cannabis access for registered patients.
Key Provisions of Senate Bill 220
Senate Bill 220 introduces several changes to Georgia’s medical cannabis program. One notable amendment is the addition of new qualifying conditions, including Lupus, which allows more patients to register for the program. Furthermore, the bill permits registered patients to legally inhale low-THC oil via a vape device.
Gary Long, CEO of Botanical Sciences, Georgia’s largest medical marijuana dispensary, stated that the vaping provision is expected to offer quicker support for patients. He noted that inhaled forms of the product may enter the bloodstream rapidly, which may be beneficial for individuals seeking prompt symptom management for conditions such as cancer, PTSD, multiple sclerosis, or chronic pain.
Doug Maddi, a 29-year army veteran who uses medical cannabis for physical and mental pain, indicated that vaping offers the fastest support for his daily needs.
Changes to Potency and Possession Limits
The new law also alters the previous 5% THC potency cap. It replaces this limit with a possession cap of 12,000 milligrams of THC that a patient can possess at any one time. This adjustment shifts the regulatory focus from a percentage-based potency limit to a total quantity of THC available to the patient.
Michael Mumper, executive director of Georgians for Responsible Marijuana Policy, expressed concerns regarding the quantity of product now accessible to patients. Mumper highlighted that 10 milligrams can produce a significant psychoactive effect, and 40 milligrams daily would allow a patient to possess a 300-day supply under the new 12,000-milligram limit. He also noted that vaping products are not approved by the U.S. Food and Drug Administration (FDA), advising patients to seek comprehensive information on appropriate use.
Legislative Context and Effective Date
Governor Kemp affirmed his support for SB 220, acknowledging the potential of medical cannabis for various symptoms. However, he reiterated his opposition to the legalization of recreational cannabis in Georgia. As previously reported by Hemp Gazette, Senate Bill 220 builds on earlier legislative efforts to refine the state’s medical cannabis framework.
The provisions of Senate Bill 220 are scheduled to take effect on July 1.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
